News & Updates

In individuals who had been on antidepressant therapy for at least 9 months but felt well enough to consider discontinuing, the risk of relapse of depression was greater among those who stopped vs those who carried on with their current regimen, the ANTLER* trial has shown.

Lifestyle interventions or bariatric surgery leading to preconceptional weight loss effectively reduces the risk of hypertensive disorders of pregnancy (HDP), such as pregnancy-induced hypertension (PIH) and pre-eclampsia (PE), reports a recent meta-analysis.

Among patients with systemic sclerosis-interstitial lung disease (SSc-ILD), radiographic progression of ILD over time is predictive of elevated long-term mortality, as shown in a study.

A large prospective, observational study has suggested that while individuals with a history of high-risk allergy may have an increased risk of allergic reactions following receipt of a messenger RNA (mRNA) COVID-19 vaccine, they are still able to receive both vaccine doses.

Use of opioid among adults with knee and/or hip osteoarthritis (OA) often leads to being familiar with the treatment and believing that the medication is beneficial and low-risk, reveals a recent study.

In individuals with clinically diagnosed mild-to-moderate Alzheimer’s disease (AD), treatment with the angiotensin II receptor blocker (ARB) losartan for 12 months did not reduce the rate of brain atrophy, findings from the phase II RADAR* trial suggest.